From The Editor

31. Using AI And ML To Gain Insight Into Optimal Glycoforms 3/28/2025

    Bioprocess Online asked Nathan Lewis, Ph.D., to briefly explain the research he presented at BPI West 2025.

32. Impressions And Takeaways From BPI West 2025 3/27/2025

    Editor Tyler Menichiello reviews the most compelling topics and sessions from this year's BioProcess International U.S. West.

33. Areas For Advancement In Peptide Manufacturing 2/27/2025

    Experts from Eli Lilly, NervGen, and Piramal Pharma Solutions discuss the myriad of ways peptide manufacturing can be improved, drawing on years of industry experience and insight.

34. For Gilead, Sustainability Is More Than A PR Effort 2/14/2025

    Gilead's chief sustainability officer and SVP of operations, Joydeep Ganguly, explains the company's cultural focus on sustainability and how it influences everything from R&D to manufacturing. 

35. GlycoNex On Challenges In Biosimilar Development, Manufacturing 1/29/2025

    In this written Q&A, GlycoNex president and CEO, Dr. Mei-Chun Yang, shares insight into the company's development of its denosumab biosimilar, SPD8. She covers the company’s approach to analytics, cell line development, scaling, and more.

36. Easing Autologous Cell Collection, Automating Manufacturing 1/22/2025

    To circumvent the challenges of leukapheresis, CellProthera developed a novel method for collecting therapeutic stem cells from whole blood. CSO Ibon Garitaonandia, Ph.D., discusses the company's mission to streamline manufacturing.

37. Industry Leaders On Analytical Method Development 1/7/2025

    Experts from Bristol Myers Squibb and Moffitt Cancer Center discuss best practices for analytical method development, as well as how to manage the successful transfer of these methods.

38. Optimism For Biopharma In 2025 12/27/2024

    In this closing segment from the executive roundtable discussion, our panelists express their confidence in the industry's mission and maintain a positive outlook for the years ahead.

39. How Biotechs Can Navigate Market Uncertainty In 2025 12/27/2024

    In this segment of the executive roundtable discussion, our panelists weigh in on how to prepare for what may be a challenging financial climate in 2025. 

40. Political Influences And Regulatory Implications For Biotech In 2025 12/27/2024

    In this segment of the executive roundtable discussion, our panelists discuss the changing political landscape and its potential effects from a regulatory and economic point of view.